An Open-Label, Multicenter, Global Phase 2 Basket Study

Project: Research project

Description

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
StatusActive
Effective start/end date9/1/158/31/21

Funding

  • IGNYTA, INC.

Fingerprint

Gene Rearrangement
Neoplasms
Therapeutics
entrectinib